Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 16434666.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In a randomized, double-blind, placebo-controlled study in 64 subjects with Huntington disease (HD), 8 g/day of creatine administered for 16 weeks was well tolerated and safe. Serum and brain creatine concentrations increased in the creatine-treated group and returned to baseline after washout. Serum 8-hydroxy-2'-deoxyguanosine (8OH2'dG) levels, an indicator of oxidative injury to DNA, were markedly elevated in HD and reduced by creatine treatment.
Medical subject headings
- Brain
- Creatine
- Deoxyguanosine
- Huntington Disease